Homocysteine in dogs with systemic inflammatory response syndrome

Loading...
Thumbnail Image

Date

Authors

Patterson, B.E.
Barr, J.W.
Fosgate, Geoffrey Theodore
Berghoff, N.
Steiner, Jorg M.
Suchodolski, J.S.
Black, D.M.

Journal Title

Journal ISSN

Volume Title

Publisher

American Society for Microbiology

Abstract

OBJECTIVES - To compare serum concentrations of homocysteine (Hcy) in dogs fitting the criteria for the systemic inflammatory response syndrome (SIRS) and healthy dogs, and compare these values to commonly measured B-vitamins. METHODS – Study dogs were classified into noninfectious SIRS or sepsis groups and blood was drawn on Day 1 of the patient’s hospitalization for the measurement of Hcy, folate and cobalamin concentrations. Hcy was measured in 51 clinically normal dogs to serve as the control group. RESULTS - A statistically significant difference was found between the Hcy concentrations of the healthy group when compared to noninfectious SIRS and sepsis groups. Hcy values were not correlated with folate, cobalamin or APPLEfast severity scores. Hcy concentrations were significantly lower in sick dogs when compared to the control group, which is dissimilar to the human population. CLINICAL SIGNIFCANCE - The clinical significance of Hcy changes in critically ill dogs is currently unknown.

Description

Keywords

Homocysteine, B-vitamins, Sepsis, Systemic inflammatory response syndrome (SIRS)

Sustainable Development Goals

Citation

Patterson, BE, Barr, JW, Fosgate, GT, Berghoff, N, Steiner, JM, Suchodolski, JS & Black, DM2014, 'Homocysteine in dogs with systemic inflammatory response syndrome', Antimicrobial Agents and Chemotherapy, vol. 57, no. 2, pp. 1050-1052.